Painkiller firm rejects potential sale
Jeff Smith could probably use a painkiller right about now. Depomed, a big player in pain treatments, recently turned down a prospective buyer despite pressure from Smith’s Starboard Capital hedge fund to sell itself, The Post has learned. Arbor Pharmaceuticals, a specialty pharmaceutical company backed by private-equity firm KKR, approached Depomed and was rejected, a...
No comments